13P The landscape of human epidermal growth factor receptor 2 (HER2) expression in gynaecologic tumors (GynT)

Key Points

• The aim is to assess HER2 expression levels in gynaecologic tumors and their clinical relevance.
• Review of existing literature on HER2 expression in gynaecologic tumors.
• Analysis of associations between HER2 expression and disease aggressiveness.
• HER2 expression varies significantly across different gynaecologic tumors.
• Higher HER2 expression is linked to more aggressive disease, but clinical implications are not yet fully understood.